PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
10939719-4	2000	As a biological function exerted by this antigen, it was of great interest that immobilized mNI-11 directly and rapidly enhanced the spread formation of HUVECs, whereas MAbs binding other adhesion-associated antigens such as mNI-58A (anti-CD11a), L130 (anti-CD18), L133.1 (anti-CD31), L178 (anti-CD44), L25.3 (anti-CD49d), or LB-2 (anti-CD54) did not carry such activity under the same conditions.	N-{[(2r,3r,4r,5r)-3,4-Dihydroxy-5-(Hydroxymethyl)pyrrolidin-2-Yl]methyl}-4-(Dimethylamino)benzamide	92-95	integrin subunit alpha L	Homo sapiens	239-244
10939719-4	2000	As a biological function exerted by this antigen, it was of great interest that immobilized mNI-11 directly and rapidly enhanced the spread formation of HUVECs, whereas MAbs binding other adhesion-associated antigens such as mNI-58A (anti-CD11a), L130 (anti-CD18), L133.1 (anti-CD31), L178 (anti-CD44), L25.3 (anti-CD49d), or LB-2 (anti-CD54) did not carry such activity under the same conditions.	N-{[(2r,3r,4r,5r)-3,4-Dihydroxy-5-(Hydroxymethyl)pyrrolidin-2-Yl]methyl}-4-(Dimethylamino)benzamide	92-95	lymphotoxin beta receptor	Homo sapiens	258-262
10939719-4	2000	As a biological function exerted by this antigen, it was of great interest that immobilized mNI-11 directly and rapidly enhanced the spread formation of HUVECs, whereas MAbs binding other adhesion-associated antigens such as mNI-58A (anti-CD11a), L130 (anti-CD18), L133.1 (anti-CD31), L178 (anti-CD44), L25.3 (anti-CD49d), or LB-2 (anti-CD54) did not carry such activity under the same conditions.	N-{[(2r,3r,4r,5r)-3,4-Dihydroxy-5-(Hydroxymethyl)pyrrolidin-2-Yl]methyl}-4-(Dimethylamino)benzamide	92-95	platelet and endothelial cell adhesion molecule 1	Homo sapiens	278-282
10939719-4	2000	As a biological function exerted by this antigen, it was of great interest that immobilized mNI-11 directly and rapidly enhanced the spread formation of HUVECs, whereas MAbs binding other adhesion-associated antigens such as mNI-58A (anti-CD11a), L130 (anti-CD18), L133.1 (anti-CD31), L178 (anti-CD44), L25.3 (anti-CD49d), or LB-2 (anti-CD54) did not carry such activity under the same conditions.	N-{[(2r,3r,4r,5r)-3,4-Dihydroxy-5-(Hydroxymethyl)pyrrolidin-2-Yl]methyl}-4-(Dimethylamino)benzamide	92-95	CD44 molecule (Indian blood group)	Homo sapiens	296-300
10939719-4	2000	As a biological function exerted by this antigen, it was of great interest that immobilized mNI-11 directly and rapidly enhanced the spread formation of HUVECs, whereas MAbs binding other adhesion-associated antigens such as mNI-58A (anti-CD11a), L130 (anti-CD18), L133.1 (anti-CD31), L178 (anti-CD44), L25.3 (anti-CD49d), or LB-2 (anti-CD54) did not carry such activity under the same conditions.	N-{[(2r,3r,4r,5r)-3,4-Dihydroxy-5-(Hydroxymethyl)pyrrolidin-2-Yl]methyl}-4-(Dimethylamino)benzamide	92-95	integrin subunit alpha 4	Homo sapiens	315-320
10939719-4	2000	As a biological function exerted by this antigen, it was of great interest that immobilized mNI-11 directly and rapidly enhanced the spread formation of HUVECs, whereas MAbs binding other adhesion-associated antigens such as mNI-58A (anti-CD11a), L130 (anti-CD18), L133.1 (anti-CD31), L178 (anti-CD44), L25.3 (anti-CD49d), or LB-2 (anti-CD54) did not carry such activity under the same conditions.	N-{[(2r,3r,4r,5r)-3,4-Dihydroxy-5-(Hydroxymethyl)pyrrolidin-2-Yl]methyl}-4-(Dimethylamino)benzamide	92-95	intercellular adhesion molecule 1	Homo sapiens	337-341